Chadi Nabhan, Chief Medical Officer and Head of Strategy at Ryght, shared a post on X by Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, adding:
“Airing soon – mark your calendar, Balazs Halmos consumed every baklawa known to man.
Thank you Estela Rodriguez for a fun conversation.”
Quoting Estela Rodriguez‘s post:
“I didn’t get Baklava this week but I got to be part of Chadi Nabhan‘s Healthcare Unfiltered Podcast covering recent updates from IASLC.
- FLAURA2 (chemo+osi)
- ARROS-1 : Zidesamtinib
- Negative Trials (Adj Crizotinib, PACIFIC2 concurrent chemoIO in Stage III )
- Changing SCLC Landscape (ADCs, DLL3-directed therapies) and more…”
More posts featuring Estela Rodriguez on OncoDaily.